ATE493492T1 - Verfahren und system zur herstellung von stammzellen aus fettgewebe - Google Patents

Verfahren und system zur herstellung von stammzellen aus fettgewebe

Info

Publication number
ATE493492T1
ATE493492T1 AT04799610T AT04799610T ATE493492T1 AT E493492 T1 ATE493492 T1 AT E493492T1 AT 04799610 T AT04799610 T AT 04799610T AT 04799610 T AT04799610 T AT 04799610T AT E493492 T1 ATE493492 T1 AT E493492T1
Authority
AT
Austria
Prior art keywords
stem cells
present
adible
tissue
preparing
Prior art date
Application number
AT04799610T
Other languages
English (en)
Inventor
Kotaro Yoshimura
Daisuke Matsumoto
Original Assignee
Biomaster Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomaster Inc filed Critical Biomaster Inc
Application granted granted Critical
Publication of ATE493492T1 publication Critical patent/ATE493492T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0667—Adipose-derived stem cells [ADSC]; Adipose stromal stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Cardiology (AREA)
  • Cell Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Virology (AREA)
AT04799610T 2003-11-04 2004-11-04 Verfahren und system zur herstellung von stammzellen aus fettgewebe ATE493492T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2003375026 2003-11-04
JP2004039099 2004-02-16
PCT/JP2004/016717 WO2005042730A2 (en) 2003-11-04 2004-11-04 Method and system for preparing stem cells from fat tissue

Publications (1)

Publication Number Publication Date
ATE493492T1 true ATE493492T1 (de) 2011-01-15

Family

ID=34554809

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04799610T ATE493492T1 (de) 2003-11-04 2004-11-04 Verfahren und system zur herstellung von stammzellen aus fettgewebe

Country Status (8)

Country Link
US (1) US9631176B2 (de)
EP (1) EP1692275B1 (de)
JP (2) JP4217262B2 (de)
KR (1) KR100821128B1 (de)
CN (1) CN1871343B (de)
AT (1) ATE493492T1 (de)
DE (1) DE602004030823D1 (de)
WO (1) WO2005042730A2 (de)

Families Citing this family (101)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7771716B2 (en) * 2001-12-07 2010-08-10 Cytori Therapeutics, Inc. Methods of using regenerative cells in the treatment of musculoskeletal disorders
US7651684B2 (en) 2001-12-07 2010-01-26 Cytori Therapeutics, Inc. Methods of using adipose tissue-derived cells in augmenting autologous fat transfer
US20050095228A1 (en) 2001-12-07 2005-05-05 Fraser John K. Methods of using regenerative cells in the treatment of peripheral vascular disease and related disorders
US9597395B2 (en) 2001-12-07 2017-03-21 Cytori Therapeutics, Inc. Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions
US7585670B2 (en) 2001-12-07 2009-09-08 Cytori Therapeutics, Inc. Automated methods for isolating and using clinically safe adipose derived regenerative cells
KR100811995B1 (ko) 2001-12-07 2008-03-10 사이토리 테라퓨틱스, 인크. 처리된 리포애스퍼레이트 세포로 환자를 치료하기 위한시스템 및 방법
US8105580B2 (en) 2001-12-07 2012-01-31 Cytori Therapeutics, Inc. Methods of using adipose derived stem cells to promote wound healing
EP2441474B1 (de) 2003-10-17 2015-08-05 Joslin Diabetes Center, Inc. Verfahren und Zusammensetzungen zur Modulation der Adipozytfunktion
US20060045872A1 (en) 2004-08-25 2006-03-02 Universidad Autonoma De Madrid Ciudad Universitaria de Cantoblanco Use of adipose tissue-derived stromal stem cells in treating fistula
ES2313805B1 (es) * 2004-10-04 2009-12-23 Cellerix, S.L. Identificacion y aislamiento de celulas multipotentes de tejido mesenquimal no osteocondral.
US20100150885A1 (en) 2005-06-01 2010-06-17 Joslin Diabetes Center, Inc. Methods and compositions for inducing brown adipogenesis
WO2006134951A1 (ja) * 2005-06-13 2006-12-21 Biomaster, Inc. 脂肪由来幹細胞の長期培養増殖法
KR100637901B1 (ko) 2005-09-12 2006-10-23 세원셀론텍(주) 성숙지방세포와 지방전구세포의 분리 배양 방법
CA2623353C (en) 2005-09-23 2017-02-21 Cellerix, S.L. Cell populations having immunoregulatory activity, method for isolation and uses
US9057052B2 (en) 2005-10-21 2015-06-16 Kaneka Corporation Stem cell separating material and method of separation
KR101083047B1 (ko) * 2005-12-16 2011-11-16 주식회사 엠씨티티 간엽줄기세포의 배양방법 및 간엽줄기세포를 포함하는 피부결함의 치료용 조성물
FR2896511B1 (fr) * 2006-01-26 2012-10-26 Centre Nat Rech Scient Procede de culture de cellules issues du tissu adipeux et leurs applications.
EP1974022B1 (de) 2006-01-27 2015-12-23 Prostemics Co., Ltd. Massenproduktionsverfahren für wachstumsfaktor unter verwendung von aus fettgewebe stammenden adulten stammzellen
WO2007129453A1 (ja) * 2006-04-19 2007-11-15 National University Corporation Nagoya University 歯周軟組織再生用組成物及びその製造方法
FR2901136B1 (fr) * 2006-05-18 2010-10-01 Centre Nat Rech Scient Utilisation de cellules derivees du tissu adipeux pour la preparation d'un medicament anti-tumoral
CN101473030A (zh) * 2006-06-15 2009-07-01 Rnl生物技术株式会社 含有来自人类脂肪组织的多塑性干细胞、成纤维细胞和脂肪或脂肪细胞的整容或整形组合物
WO2008013863A2 (en) * 2006-07-26 2008-01-31 Cytori Therapeutics, Inc. Generation of adipose tissue and adipocytes
WO2008018450A1 (en) * 2006-08-08 2008-02-14 National University Corporation Nagoya University Cell preparation containing multipotential stem cells originating in fat tissue
EP2201910B1 (de) * 2007-06-01 2013-04-03 Allergan, Inc. Gerät zur Erzeugung des zugspannungsinduzierten Wachstums von biologischem Gewebe
US9845458B2 (en) * 2007-06-14 2017-12-19 Akifumi Matsuyama Multipotent progenitor cell derived from adipose tissue
JP2009001509A (ja) * 2007-06-19 2009-01-08 Univ Nagoya 脂肪組織由来幹細胞を用いた組織再生用組成物
US20110206614A1 (en) * 2007-11-23 2011-08-25 Whitehead Institute For Biomedical Research Systemic instigation systems to study tumor growth or metastasis
WO2009070767A2 (en) * 2007-11-28 2009-06-04 Whitehead Institute For Biomedical Research Systemic instigation systems to study tumor growth or metastasis
US20090181104A1 (en) * 2007-12-14 2009-07-16 Gino Rigotti Breast reconstruction or augmentation using computer-modeled deposition of processed adipose tissue
EP2620139B1 (de) 2008-02-27 2016-07-20 Biomet Biologics, LLC Interleukin-1-Rezeptorantagonisten-reiche Lösungen
WO2010021993A1 (en) * 2008-08-19 2010-02-25 Cytori Therapeutics, Inc. Methods of using adipose tissue-derived cells in the treatment of the lymphatic system and malignant disease
AU2009201915C1 (en) 2008-08-22 2015-02-26 Regeneus Ltd Therapeutic methods
US20110208162A1 (en) * 2008-10-24 2011-08-25 Indiana University Rsearch and Technology Corporation Methods for preventing aggregation of adipose stromal cells
AU2009317874B2 (en) 2008-11-20 2016-04-21 Mesoblast, Inc. Method for treating or preventing a pancreatic dysfunction
CN101748096B (zh) * 2008-12-17 2013-03-13 北京汉氏联合生物技术有限公司 亚全能干细胞、其制备方法及其用途
WO2010127310A1 (en) * 2009-05-01 2010-11-04 Cytori Therapeutics, Inc. Systems, methods and compositions for optimizing tissue and cell enriched grafts
JP2011004705A (ja) * 2009-06-29 2011-01-13 Olympus Corp 細胞分離装置および細胞分離方法
US20110027239A1 (en) * 2009-07-29 2011-02-03 Tissue Genesis, Inc. Adipose-derived stromal cells (asc) as delivery tool for treatment of cancer
US20110052561A1 (en) * 2009-08-27 2011-03-03 Biomet Biologics,LLC Osteolysis treatment
JP5678360B2 (ja) * 2009-09-28 2015-03-04 株式会社ジーシー 間葉系幹細胞の培養方法
EP2489727A4 (de) 2009-10-08 2013-05-08 Seoul Nat Univ Hospital Verfahren zur herbeiführung einer hohen aktivität menschlicher adipositas-stammzellen und medium dafür
JP2011097878A (ja) * 2009-11-06 2011-05-19 Olympus Corp 細胞分離装置
JP5668075B2 (ja) 2009-11-17 2015-02-12 ヤング リー，ヒー 幹細胞の分離方法
WO2011073521A1 (en) * 2009-12-15 2011-06-23 Petri Salven Methods for enriching adult-derived endothelial progenitor cells and uses thereof
AT509071B1 (de) 2010-01-29 2011-06-15 Heinrich Karl Georg Ddr Verfahren zur reinigung mesenchymaler stammzellen
US8883210B1 (en) 2010-05-14 2014-11-11 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US9352003B1 (en) 2010-05-14 2016-05-31 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US10130736B1 (en) 2010-05-14 2018-11-20 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
EP2584029B1 (de) * 2010-07-29 2017-06-21 Terumo Kabushiki Kaisha Bahnenförmiges zellkultur-dissoziationssystem
SG191206A1 (en) * 2010-12-17 2013-07-31 Cell Ideas Pty Ltd Arthroscopy method
CA2823123A1 (en) 2010-12-27 2012-07-05 Intellicell Biosciences, Inc. Ultrasonic cavitation derived stromal or mesenchymal vascular extracts and cells derived therefrom obtained from adipose tissue and use thereof
JP2014506453A (ja) 2011-01-19 2014-03-17 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 生得的多能性体細胞
CN109730959A (zh) * 2011-03-28 2019-05-10 约翰·S·阿诺尼 基于干细胞的化妆配制品及制备其的方法和系统
US8834928B1 (en) 2011-05-16 2014-09-16 Musculoskeletal Transplant Foundation Tissue-derived tissugenic implants, and methods of fabricating and using same
CN102485885A (zh) * 2011-06-09 2012-06-06 臻景生物技术（上海）有限公司 脂肪干细胞的分离方法和用途
ES2600321T3 (es) 2011-08-04 2017-02-08 Ethianum Betriebsgesellschaft Mbh & Co. Kg Medios para la regeneración del hígado
WO2013060283A1 (zh) * 2011-10-28 2013-05-02 Li Fusheng 凝集素用于识别、纯化干细胞的方法、试剂盒及其应用方法
WO2013060282A1 (zh) * 2011-10-28 2013-05-02 Lu Leilei 用于富集、提纯干细胞的方法、试剂盒及其应用方法
CN104203257A (zh) 2012-02-24 2014-12-10 佐伯正典 含有脂肪细胞的细胞制剂
JP2013063088A (ja) * 2012-12-14 2013-04-11 Nippon Institute For Biological Science 脂肪組織間質細胞の神経細胞への分化誘導方法
US20140271589A1 (en) 2013-03-15 2014-09-18 Biomet Biologics, Llc Treatment of collagen defects using protein solutions
US9878011B2 (en) 2013-03-15 2018-01-30 Biomet Biologics, Llc Treatment of inflammatory respiratory disease using biological solutions
US10208095B2 (en) 2013-03-15 2019-02-19 Biomet Manufacturing, Llc Methods for making cytokine compositions from tissues using non-centrifugal methods
US10143725B2 (en) 2013-03-15 2018-12-04 Biomet Biologics, Llc Treatment of pain using protein solutions
US9895418B2 (en) 2013-03-15 2018-02-20 Biomet Biologics, Llc Treatment of peripheral vascular disease using protein solutions
US9758806B2 (en) 2013-03-15 2017-09-12 Biomet Biologics, Llc Acellular compositions for treating inflammatory disorders
EP3027235A1 (de) 2013-07-30 2016-06-08 Musculoskeletal Transplant Foundation Aus einem azellulären weichgewebe gewonnene matrizen und verfahren zur herstellung davon
RU2554843C2 (ru) * 2013-08-08 2015-06-27 Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт фармакологии и регенеративной медицины имени Е.Д.Гольдберга" (НИИФиРМ им.Е.Д.Гольдберга) Способ получения и индукции направленной дифференцировки культуры мультипотентных клеток легких
KR101398764B1 (ko) 2013-08-29 2014-05-27 강릉원주대학교산학협력단 입자의 이동에 의해 분석물질을 검출하는 장치 및 방법
WO2015038951A1 (en) * 2013-09-12 2015-03-19 Ohio State Innovation Foundation Topical compounds containing adipose-derived hormones for the rejuvenation of skin
US9404086B2 (en) * 2014-03-26 2016-08-02 Ge Healthcare Uk Limited Method for cell differentiation
JP6498470B2 (ja) * 2015-02-20 2019-04-10 デクセリアルズ株式会社 透明導電膜およびその製造方法
KR101719743B1 (ko) 2015-04-06 2017-03-24 박준한 지방 조직으로부터 지방줄기세포를 수득하는 방법
EP3297694A1 (de) 2015-05-21 2018-03-28 Musculoskeletal Transplant Foundation Modifizierte demineralisierte kortikale knochenfasern
US10912864B2 (en) 2015-07-24 2021-02-09 Musculoskeletal Transplant Foundation Acellular soft tissue-derived matrices and methods for preparing same
US11052175B2 (en) 2015-08-19 2021-07-06 Musculoskeletal Transplant Foundation Cartilage-derived implants and methods of making and using same
CN105112367B (zh) * 2015-08-28 2018-07-27 青岛瑞思科生物科技有限公司 一种间充质干细胞表皮分化诱导剂及其应用方法
GB201604304D0 (en) 2016-03-14 2016-04-27 Tigenix S A U Adipose tissue-derived stromal stem cells for use in treating refractory complex perianal fistulas in crohn's disease
WO2017195225A1 (en) 2016-05-10 2017-11-16 Promoitalia Group Spa Method for extracting and separating stem cells derived from adipose tissue for aesthetic treatments
CN107475184A (zh) * 2016-06-07 2017-12-15 广州美萨生物科技有限公司 一种用于培养人间充质干细胞的低血清培养基
CN107475185A (zh) * 2016-06-07 2017-12-15 杨旅军 一种用于培养人间充质干细胞的无动物源成分培养基
IL295611B2 (en) 2016-06-08 2023-11-01 Univ California Method and device for processing tissues and cells
CN106754676B (zh) * 2016-12-21 2018-02-13 广东康仹生命科技有限公司 用于保护脂肪组织的组合物及其制备方法和用途
GB201703058D0 (en) 2017-02-24 2017-04-12 Ucl Business Plc Biomarkers
EP3645066B1 (de) 2017-06-30 2026-04-15 Allosource Zelluläre knochentransplantate, verfahren zur herstellung und verwendung
KR102118522B1 (ko) 2017-10-25 2020-06-03 (주)셀라토즈테라퓨틱스 신규한 근골격계 줄기세포
JP7628689B2 (ja) * 2017-11-14 2025-02-12 学校法人自治医科大学 血管内皮（前駆）細胞を含む細胞集団、その製造方法、及び医薬組成物
WO2019161540A1 (zh) * 2018-02-23 2019-08-29 高扬 一种基于多能干细胞分化再生的延缓机体衰老的美容制剂
CN108410800B (zh) * 2018-03-26 2019-02-22 郭子宽 一种培养人羊膜上皮细胞的培养基及应用
IL306070A (en) 2018-05-03 2023-11-01 Collplant Ltd Dermal fillers and their uses
CN112135606A (zh) 2018-07-04 2020-12-25 佐伯正典 干细胞滤液制剂和其制备方法
CN109097325A (zh) * 2018-08-01 2018-12-28 丁彬彬 一种用于美容保养的脂肪干细胞液的制备方法
JP2020143008A (ja) * 2019-03-05 2020-09-10 達也 楠堂 新規褐色脂肪細胞分化誘導剤
CN110201231A (zh) * 2019-05-24 2019-09-06 丁云凤 Ai微米艺术脂雕填充物的制备方法及设备
MX2022011245A (es) 2020-03-11 2023-01-11 Bit Bio Ltd Método de generación de células hepáticas.
CN115335509A (zh) * 2020-03-27 2022-11-11 李晙硕 利用机械方式对构成活体组织的组织及细胞进行分离的方法
CN111514301A (zh) * 2020-05-21 2020-08-11 中山大学 Tgf信号抑制剂在防治癌性贫血中的应用
US20230075134A1 (en) * 2021-08-31 2023-03-09 Joshua Medical Holdings Co. Ltd. Method for isolating and purifying mesenchymal stem cells from hernia sac and method for tissue repair by using mesenchymal stem cells from hernia sac
CN113750117B (zh) * 2021-09-30 2024-01-09 成都世联康健生物科技有限公司 从吸脂废液中制备的脂肪组织精华、其制备方法和应用
SMT202500501T1 (it) * 2023-05-31 2026-03-09 Linio Biotech Ltd Preparazione derivata da lipoaspirato priva di cellule, composizioni comprendenti la preparazione e usi di essa
WO2024246429A1 (en) 2023-05-31 2024-12-05 Linio Biotech Ltd Cell-free lipoaspirate-derived preparation, compositions comprising the preparation and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL145002A0 (en) * 1999-03-10 2002-06-30 Univ Pittsburgh Adipose-derived stem cells and lattices
US6777231B1 (en) * 1999-03-10 2004-08-17 The Regents Of The University Of California Adipose-derived stem cells and lattices
US20030082152A1 (en) 1999-03-10 2003-05-01 Hedrick Marc H. Adipose-derived stem cells and lattices
PT1261694E (pt) * 2000-02-26 2008-04-03 Artecel Inc Células estaminais pluripotentes produzidas a partir de células estromais derivadas de tecido adiposo e suas utilizações.
US7514075B2 (en) * 2001-12-07 2009-04-07 Cytori Therapeutics, Inc. Systems and methods for separating and concentrating adipose derived stem cells from tissue
WO2005035738A1 (en) * 2003-10-07 2005-04-21 Biomaster Inc. Cell differentiation of adipose-derived precursor cells

Also Published As

Publication number Publication date
CN1871343A (zh) 2006-11-29
JP2007509601A (ja) 2007-04-19
WO2005042730A2 (en) 2005-05-12
US20070148766A1 (en) 2007-06-28
CN1871343B (zh) 2013-06-26
EP1692275B1 (de) 2010-12-29
EP1692275A2 (de) 2006-08-23
DE602004030823D1 (de) 2011-02-10
KR20060037469A (ko) 2006-05-03
JP4217262B2 (ja) 2009-01-28
JP2008188021A (ja) 2008-08-21
WO2005042730A3 (en) 2005-09-29
US9631176B2 (en) 2017-04-25
KR100821128B1 (ko) 2008-04-14

Similar Documents

Publication Publication Date Title
DE602004030823D1 (de) Verfahren und system zur herstellung von stammzellen aus fettgewebe
ATE458506T1 (de) Knochenmarkersatzmaterial-verbundwerkstoff, verfahren zu seiner herstelllung und kit
DE602004027188D1 (de) Verfahren zur Herstellung bioabsorbierbarer, poröser und verstärkter Gewebeimplantate und dadurch hergestellte Implantate
MX2007007723A (es) Un biomaterial implantable y un metodo para producirlo.
ATE455463T1 (de) Verfahren zur herstellung gefriergetrockneter blutplättchen, gefriergetrocknete blutplättchen enthaltende zusammensetzungen und verwendungsverfahren
WO2007067280A3 (en) Very small embryonic-like (vsel) stem cells and methods of isolating and using the same
ATE555798T1 (de) Gewebeimplantate und verfahren zur ihrer herstellung und verwendung
WO2007010305A3 (en) Surgical membrane
EP1449500A3 (de) Modulares Knochenimplantat, Werkzeug und Verfahren
ATE524121T1 (de) Vorrichtungen zur platzierung eines orthopädischen intervertebralen implantats
ATE554725T1 (de) Chirurgische artikel zur behandlung von beckenerkrankungen
ATE530142T1 (de) Chirurgische artikel zur behandlung von beckenerkrankungen
WO2005051233A3 (en) Computer-aided tissue engineering of a biological body
ATE477224T1 (de) Verwendung von miniatursierten vorrichtungen zur herstellung von radiomarkierten verbindungen
EP3238665A3 (de) Diffusionsgehärtetes medizinisches implantat
WO2009059032A3 (en) Uses and isolation of very small embryonic-like (vsel) stem cells
ATE520372T1 (de) Poröses implantat für den bandscheibennukleus- ersatz
EP1789088A4 (de) Verfahren zur durchführung von medizinischen verfahren zur förderung des knochenwachstums, verfahren zur herstellung von zusammensetzungen zur förderung des knochenwachstums und gerät zur verwendung bei solchen verfahren
ATE529409T1 (de) Verfahren zur herstellung von kristallinen aripiprazolformen
WO2004031129A3 (en) Compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection
ATE296123T1 (de) Verfahren zur herstellung bioaktiver implantatoberflächen
DE602005026866D1 (de) Vewendung von dreidimensionalem kultiviertem gewebe zur behandlung von kongestivem herzversagen
EP1642600A4 (de) Medizinisches knochenprothesematerial und verfahren zu seiner herstellung
DE50103247D1 (de) Knochenersatzmaterial
DE50312433D1 (de) Gezüchtete knorpelzellen beinhaltendes implantat und verfahren zur herstellung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties